Pith. sign in

REVIEW 3 cited by

Double-robust and efficient methods for estimating the causal effects of a binary treatment

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2008.00507 v1 pith:MHUKI6PY submitted 2020-08-02 stat.ME

classification stat.ME
keywords treatmenteffectestimatorsapproachaveragedouble-robustestimatoroutcome
verification ladder T0 review T1 audit T2 compute T3 formal

Signed reviews

No signed human review yet.

0 comments
abstract

We consider the problem of estimating the effects of a binary treatment on a continuous outcome of interest from observational data in the absence of confounding by unmeasured factors. We provide a new estimator of the population average treatment effect (ATE) based on the difference of novel double-robust (DR) estimators of the treatment-specific outcome means. We compare our new estimator with previously estimators both theoretically and via simulation. DR-difference estimators may have poor finite sample behavior when the estimated propensity scores in the treated and untreated do not overlap. We therefore propose an alternative approach, which can be used even in this unfavorable setting, based on locally efficient double-robust estimation of a semiparametric regression model for the modification on an additive scale of the magnitude of the treatment effect by the baseline covariates $X$. In contrast with existing methods, our approach simultaneously provides estimates of: i) the average treatment effect in the total study population, ii) the average treatment effect in the random subset of the population with overlapping estimated propensity scores, and iii) the treatment effect at each level of the baseline covariates $X$. When the covariate vector $X$ is high dimensional, one cannot be certain, owing to lack of power, that given models for the propensity score and for the regression of the outcome on treatment and $X$ used in constructing our DR estimators are nearly correct, even if they pass standard goodness of fit tests. Therefore to select among candidate models, we propose a novel approach to model selection that leverages the DR-nature of our treatment effect estimator and that outperforms cross-validation in a small simulation study.

Discussion (0). Continue with ORCID to comment.

Forward citations

Cited by 3 Pith papers

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score. Full citation record

  1. Modeling Time-course Gene Expression Data through Bayesian Partition Functional Principal Component Analysis

    stat.ME 2026-07 conditional novelty 6.0 of 10

    A Bayesian mixture of multivariate FPCAs jointly infers gene partitions and shared temporal scores, recovering true groups far more often than two-step FPCA-plus-clustering and revealing influenza immune signatures.

  2. FLAME: A Model for Duration-Dependent Risk Accumulation in Episodic Temporal Exposures

    stat.ME 2025-06 conditional novelty 5.0 of 10

    FLAME models outcome risk as a sum of an unknown duration-response curve over individual exposure episodes, and its cardiac surgery application estimates that sustained hypotension raises AKI risk more per minute than...

  3. Uncovering dynamics between SARS-CoV-2 wastewater concentrations and community infections via Bayesian spatial functional concurrent regression

    stat.ME 2024-12 conditional novelty 5.0 of 10

    A Bayesian spatial functional concurrent regression model estimates a 5-11 day lead time from wastewater SARS-CoV-2 levels to clinical positivity rates, with a time-varying association that weakens during outbreaks.

Pith tools